Deutsche Bank
IMDX

Deutsche Bank’s Insight Molecular Diagnostics IMDX Stock Holding History

Deutsche Bank’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,695
Closed -$12K – 3885
2023
Q1 		$12K Sell
1,695
-1,689
-50% -$12.5K ﹤0.01% 3765
2022
Q4 		$21.7K Hold
3,384
– – ﹤0.01% 3760
2022
Q3 		$49K Hold
3,384
– – ﹤0.01% 3600
2022
Q2 		$61K Buy
3,384
+824
+32% +$18.7K ﹤0.01% 3702
2022
Q1 		$77K Buy
2,560
+623
+32% +$19.9K ﹤0.01% 3677
2021
Q4 		$84K Sell
1,937
-603
-24% -$34.7K ﹤0.01% 3775
2021
Q3 		$181K Buy
2,540
+255
+11% +$23.4K ﹤0.01% 3619
2021
Q2 		$263K Sell
2,285
-75
-3% -$7.32K ﹤0.01% 3625
2021
Q1 		$245K Buy
2,360
+35
+2% +$3.32K ﹤0.01% 3525
2020
Q4 		$111K Buy
2,325
+634
+37% +$23.3K ﹤0.01% 3791
2020
Q3 		$47K Buy
1,691
+581
+52% +$16.7K ﹤0.01% 3919
2020
Q2 		$42K Buy
1,110
+757
+214% +$39.1K ﹤0.01% 3890
2020
Q1 		$17K Sell
353
-22
-6% -$1.08K ﹤0.01% 3949
2019
Q4 		$16K Buy
375
+75
+25% +$2.71K ﹤0.01% 4365
2019
Q3 		$11K Sell
300
-509
-63% -$20K ﹤0.01% 4480
2019
Q2 		$40K Sell
809
-8,627
-91% -$717K ﹤0.01% 4602
2019
Q1 		$744K Buy
+9,436
New +$608K ﹤0.01% 3184
2018
Q3 		– Sell
-76
Closed -$4K – 5489
2018
Q2 		$4K Sell
76
-177
-70% -$8.72K ﹤0.01% 5278
2018
Q1 		$10K Sell
253
-170
-40% -$11.2K ﹤0.01% 5145
2017
Q4 		$39K Buy
423
+236
+126% +$26.6K ﹤0.01% 4525
2017
Q3 		$28K Sell
187
-20
-10% -$2.1K ﹤0.01% 4503
2017
Q2 		$21K Buy
207
+167
+418% +$19K ﹤0.01% 4555
2017
Q1 		$4K Buy
40
+39
+3,900% +$4.5K ﹤0.01% 4727
2016
Q4 		$0 Sell
1
-118
-99% -$13K ﹤0.01% 5028
2016
Q3 		$11K Sell
119
-23
-16% -$1.86K ﹤0.01% 4651
2016
Q2 		$9K Buy
142
+54
+61% +$5.05K ﹤0.01% 4932
2016
Q1 		$6K Buy
+88
New +$7.79K ﹤0.01% 4929

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's IMDX Position: Q2 2023 in Review

Deutsche Bank sold out of Insight Molecular Diagnostics (IMDX) in Q2 2023, closing a stake of 1,695 shares — an estimated $12K sold.

Deutsche Bank first reported a position in IMDX in Q1 2016 and held it in 27 quarters. The position peaked at $744K in Q1 2019. 47 funds tracked by Wall St. Rank hold IMDX as of Q2 2023.

  • Deutsche Bank reported no remaining Insight Molecular Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Deutsche Bank sold 1,695 Insight Molecular Diagnostics shares in Q2 2023, an estimated $12K.
  • Deutsche Bank first reported a position in Insight Molecular Diagnostics in Q1 2016 and held it in 27 quarters.
  • Deutsche Bank's Insight Molecular Diagnostics position peaked at $744K in Q1 2019.
  • 47 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2023.

Based on Deutsche Bank's 13F filing for Q2 2023, filed 14 Aug 2023.